The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Open accessAbstract
The Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC) is an expert-curated description of the genes driving human cancer that is used as a standard in cancer genetics across basic research, medical reporting and pharmaceutical development. After a major expansion and complete re-evaluation, the 2018 CGC describes in detail the effect of 719 cancer-driving genes. The recent expansion includes functional and mechanistic descriptions of how each gene contributes to disease generation in terms of the key cancer hallmarks and the impact of mutations on gene and protein function. These functional characteristics depict the extraordinary complexity of cancer biology and suggest multiple cancer-related functions for many genes, which are often highly tissue-dependent or tumour stage-dependent. The 2018 CGC encompasses a second tier, describing an expanding list of genes (currently 145) from more recent cancer studies that show supportive but less detailed indications of a role in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We identified 391 out of the 622 curated COSMIC cancer-related and AML-related genes located inside the altered TADs in at least one sample, and more than 100 are recurrent across multiple samples (Extended Data Fig. 3b)4,24,25.”
From Subtype-specific 3D genome alteration in acute myeloid leukaemia (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“four interact with or signal through KRAS16,38 or are known oncogenes or tumor suppressors39: TP53, RNF43, MAP2K4, and RBM10”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Cited by
Sorted by citations
Items 601–700 of 998
Parvandeh, S., Donehower, L. A., Katsonis, P., Hsu, T., Asmussen, J. K., Lee, K. D., & Lichtarge, O. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac215 · Cited by 11
Li, F., Chu, X., Dai, L.-Y., Wang, J., Liu, J., & Shang, J. (2022) · Genes · doi:10.3390/genes13050716 · Cited by 11
Driver gene detection through Bayesian network integration of mutation and expression profiles
Chen, Z., Lü, Y., Cao, B., Zhang, W., Edwards, A., & Zhang, K. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac203 · Cited by 11
Systemic circulating microRNA landscape in Lynch syndrome
Sievänen, T., Korhonen, T.-M. K., Jokela, T. A., Ahtiainen, M., Lahtinen, L., Kuopio, T., Lepistö, A., Sillanpää, E., Mecklin, J., Seppälä, T. T., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34338 · Cited by 11
Li, X., Zhang, X., Lin, X., Cai, L., Wang, Y., & Chang, Z. (2022) · Genes · doi:10.3390/genes13101913 · Cited by 11
Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas
Chang, Y., Tu, S.-J., Chen, H.-D., Chung, C., Hsu, M.-H., Chou, Y., Lee, Y.-T., Yen, J.-C., Jeng, L., & Chang, J. (2023) · Biomarker Research · doi:10.1186/s40364-023-00492-7 · Cited by 11
Supervised Prediction of Aging-Related Genes From a Context-Specific Protein Interaction Subnetwork
Li, Q., & Milenković, T. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3076961 · Cited by 11
M6ADD: a comprehensive database of m6A modifications in diseases
Zhou, D., Wang, H., Bi, F., Xing, J., Gu, Y., Wang, C., Zhang, M., Huang, Y., Zeng, J., Wu, Q., et al. (2021) · RNA Biology · doi:10.1080/15476286.2021.1913302 · Cited by 11
Jiang, L., Chen, Q., Bei, M., Shao, M., & Xu, J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.09.019 · Cited by 10
How the germline informs the somatic landscape
Chanock, S. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00960-6 · Cited by 11
Lee, Y., Baumhardt, J. M., Pei, J., Chook, Y. M., & Grishin, N. V. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz657 · Cited by 11
Cutigi, J. F., Evangelista, R. F., Ramos, R. H., Ferreira, C. D. O. L., Evangelista, A. F., de Carvalho, A. C. P. L. F., & Simao, A. D. S. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-65775-8_8 · Cited by 11
López‐Cortés, A., Paz‐y‐Miño, C., Guerrero, S. X., Cabrera‐Andrade, A., Barigye, S. J., Munteanu, C. R., González‐Díaz, H., Pazos, A., Pérez‐Castillo, Y., & Tejera, E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/638866 · Cited by 12
Multi-omic stratification of the missense variant cysteinomePreprint
Desai, H. S., Ofori, S., Boatner, L. M., Yu, F., Villanueva, M., Ung, N., Nesvizhskii, A. I., & Backus, K. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.12.553095 · Cited by 11
DeepSom: a CNN-based approach to somatic variant calling in WGS samples without a matched normal
Вилов, С. А., & Heinig, M. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btac828 · Cited by 10
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene
Fierheller, C. T., Alenezi, W. M., Serruya, C., Revil, T., Amuzu, S., Bédard, K., Subramanian, D., Fewings, E., Bruce, J. P., Prokopec, S. D., et al. (2023) · Genes · doi:10.3390/genes14020277 · Cited by 9
Imre, G., Takács, B., Czipa, E., Drubi, A. B., Jaksa, G., Latinovics, D., Nagy, A., Karkas, R., Hudoba, L., Vásárhelyi, B. M., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.03.003 · Cited by 12
Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers
Ershov, P., Yablokov, E. O., Mezentsev, Y. V., & Ivanov, A. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210190 · Cited by 10
Pacelli, C., Rossi, A., Milella, M., Colombo, T., & Pera, L. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914862 · Cited by 10
An atlas of cell-type-specific interactome networks across 44 human tumor types
Li, Z., Liu, G., Yang, X., Shu, M., Jin, W., Tong, Y., Liu, X., Wang, Y., Yuan, J., & Yang, Y. (2024) · Genome Medicine · doi:10.1186/s13073-024-01303-w · Cited by 10
Yue, W., Li, X., Zhan, X., Wang, L., Ma, J., Bi, M., Wang, Q., Gu, X., Xie, B., Liu, T., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105129 · Cited by 10
Genetic variants for head size share genes and pathways with cancer
Knol, M. J., Poot, R. A., Evans, T. E., Satizábal, C. L., Mishra, A., Sargurupremraj, M., der Auwera, S. V., Duperron, M., Jian, X., Hostettler, I. C., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101529 · Cited by 14
Molecular models of bidirectional promoter regulation
Nemsick, S., & Hansen, A. S. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102865 · Cited by 11
Proteogenomic insights into the biology and treatment of pan-melanoma
Hang, X., Luo, R., Wang, Y., Yang, B., Xu, S., Huang, W. C., Tang, S., Fang, R., Chen, L., Zhu, N., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00688-7 · Cited by 11
Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas
Khamaiseh, S., Äyräväinen, A., Arffman, M., Reinikka, S., Mehine, M. M., Härkki, P., Bützow, R. C., Pasanen, A. M., & Vahteristo, P. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.06.051 · Cited by 10
Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkit
Lavikka, K., Oikkonen, J., Li, Y., Muranen, T., Micoli, G., Marchi, G., Lahtinen, A., Huhtinen, K., Lehtonen, R., Hietanen, S., et al. (2024) · GigaScience · doi:10.1093/gigascience/giae040 · Cited by 10
Yang, J., Fu, H., Xue, F., Li, M., Wu, Y., Yu, Z., Luo, H., Gong, J., Niu, X., & Zhang, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae418 · Cited by 10
Jensen, J. L., Bobek, O. J., Chan, I. C. C., Miller, B. C., Hillman, D. W., Heller, G., Druley, T. E., Armstrong, A. J., Morris, M. J., Milowsky, M. I., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0803 · Cited by 12
Felsheim, B., Fernández-Martínez, A., Fan, C., Pfefferle, A. D., Hayward, M. C., Hoadley, K. A., Rashid, N. U., Tolaney, S. M., Somlo, G., Carey, L., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00740-z · Cited by 11
Strategies to include prior knowledge in omics analysis with deep neural networks
Thapa, K., Kinali, M., Pei, S., Luna, A., & Babur, Ö. (2025) · Patterns · doi:10.1016/j.patter.2025.101203 · Cited by 15
Abraham, J. P., Domenyuk, V., Perdigones, N., Klimov, S., Antani, S., Yoshino, T., Heath, E. I., Lou, E., Liu, S. V., Marshall, J. L., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08986-0 · Cited by 11
Whole-Genome Methylation Study of Congenital Lung Malformations in Children
Patrizi, S. T., Pederiva, F., & D’Adamo, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.689833 · Cited by 12
Holý, P., Hlaváč, V., Ostašov, P., Brynychová, V., Koževnikovová, R., Trnková, M., Kopečková, K., Měšťáková, S., Mrhalová, M., & Souček, P. (2022) · Biochimie · doi:10.1016/j.biochi.2022.04.015 · Cited by 10
End-to-End Learning for Image-Based Detection of Molecular Alterations in Digital Pathology
Teichmann, M., Aichert, A., Bohnenberger, H., Ströbel, P., & Heimann, T. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-16434-7_9 · Cited by 9
Weisskittel, T., Cao, A., Meng-Lin, K., Lehmann, Z., Feng, B., Correia, C., Zhang, C., Wisniewski, P., Zhu, S., Ung, C. Y., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16050752 · Cited by 10
Predicting drug response through tumor deconvolution by cancer cell lines
Hsu, Y.-C., Chiu, Y., Lu, T., Hsiao, T., & Chen, Y. (2024) · Patterns · doi:10.1016/j.patter.2024.100949 · Cited by 10
Estimating the Frequency of Single Point Driver Mutations across Common Solid Tumours
Darbyshire, M., du Toit, Z. D., Rogers, M. F., Gaunt, T. R., & Campbell, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-48765-2 · Cited by 10
Tumor suppressor genes and allele-specific expression: mechanisms and significance
Clayton, E. A., Khalid, S., Ban, D., Wang, L., Jordan, I. K., & McDonald, J. F. (2020) · Oncotarget · doi:10.18632/oncotarget.27468 · Cited by 12
Liu, X., Takata, S., Ashikawa, K., Aoi, T., Kosugi, S., Terao, C., Parrish, N. F., Matsuda, K., Nakagawa, H., Kamatani, Y., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00224 · Cited by 11
Tudini, E., Davidson, A. L., Dressel, U., Andrews, L., Antill, Y. C., Crook, A., Field, M. J., Gattas, M. R., Harris, R., Kirk, J., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107140 · Cited by 10
Chen, Y., Li, H., Li, Y., & Li, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.560997 · Cited by 10
Kikutake, C., Yoshihara, M., & Suyama, M. (2021) · NAR Cancer · doi:10.1093/narcan/zcab008 · Cited by 11
McKim, K. L., Myers, M. B., Harris, K. L., Gong, B., Xu, J., & Parsons, B. L. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab040 · Cited by 10
Varela, N., Guevara‐Ramírez, P., Acevedo, C., Zambrano, T., Armendáriz‐Castillo, I., Guerrero, S. X., Quiñones, L. A., & López‐Cortés, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630658 · Cited by 10
driveR: a novel method for prioritizing cancer driver genes using somatic genomics data
Ülgen, E., & Sezerman, O. U. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04203-7 · Cited by 10
Kuiken, H. J., Dhakal, S., Selfors, L. M., Friend, C. M., Zhang, T., Callari, M., Schackmann, R. C. J., Gray, G. K., Crowdis, J. P., Bhang, H.-E. C., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02075-y · Cited by 9
Lee, C., Modave, E., Boeckx, B., Stacchiotti, S., Rutkowski, P. L., Blay, J., Dêbiec‐Rychter, M., Sciot, R., Lambrechts, D., Woźniak, A., et al. (2021) · Cancers · doi:10.3390/cancers13236057 · Cited by 10
Imamura, T., Okamura, Y., Ohshima, K., Uesaka, K., Sugiura, T., Ito, T., Yamamoto, Y., Ashida, R., Ohgi, K., Otsuka, S., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4571 · Cited by 9
Lin, L., Chen, L., Xie, Z., Chen, J., Li, L., & An, L. K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.905238 · Cited by 10
TRIM28 congenital predisposition to Wilms’ tumor: novel mutations and presentation in a sibling pairPreprint
Moore, C. E., Monforte, H. L., Teer, J. K., Zhang, Y., Yoder, S., Brohl, A. S., & Reed, D. R. (2020) · Molecular Case Studies · doi:10.1101/mcs.a004796 · Cited by 10
How often is each gene mutated within the cancer patient population?
Mendiratta, G., Jones, M. K., & Stites, E. C. (2022) · Molecular & Cellular Oncology · doi:10.1080/23723556.2022.2065176 · Cited by 10
A full-proteome, interaction-specific characterization of mutational hotspots across human cancersPreprint
Chen, S., Liu, Y., Zhang, Y., Wierbowski, S. D., Lipkin, S. M., Wei, X., & Yu, H. (2021) · Genome Research · doi:10.1101/gr.275437.121 · Cited by 9
Leveraging Gene Redundancy to Find New Histone Drivers in Cancer
Ostroverkhova, D. S., Espiritu, D., Aristizabal, M. J., & Panchenko, A. R. (2023) · Cancers · doi:10.3390/cancers15133437 · Cited by 8
Identifying cancer driver genes in individual tumours
Gillman, R., Field, M. A., Schmitz, U., Karamatic, R., & Hebbard, L. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.019 · Cited by 9
Lee, S., Park, J., Piao, Y., Lee, D., Lee, D., & Kim, S. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.038 · Cited by 9
Cancer drug sensitivity estimation using modular deep Graph Neural Networks
Campana, P. A., Prasse, P., Lienhard, M., Thedinga, K., Herwig, R., & Scheffer, T. (2024) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqae043 · Cited by 9
CancerGATE: Prediction of cancer-driver genes using graph attention autoencoders
Jung, S., Wang, S., & Lee, D. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108568 · Cited by 10
Ouyang, Z., Liu, F., Li, W., Wang, J., Chen, B., Zheng, Y., Li, Y., Tao, H., Xu, X., Li, C., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae441 · Cited by 9
Wang, Z., Gao, L., Jia, Z., Liu, L., Gu, A., Liu, Z., Zhu, Q., Zuo, Y., Yang, M., Wang, S., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02150-w · Cited by 10
Tamoxifen induces PI3K activation in uterine cancer
Kübler, K., Nardone, A., Anand, S. K., Gurevich, D., Gao, J., Droog, M., Hermida‐Prado, F., Akhshi, T. K., Feiglin, A., Feit, A. S., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02308-w · Cited by 9
Genetic Factors Involved in Cardiomyopathies and in Cancer
Molina, M. S., Peñalver, M. N., Muñoz‐Esparza, C., Esteban-Gil, Á., Mateo, J. J. S., & Gimeno, J. R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061702 · Cited by 8
Hasaart, K., Manders, F., Ubels, J., Verheul, M., van Roosmalen, M. J., Groenen, N. M., Oka, R., Kuijk, E., Lopes, S. M. C. D. S., & van Boxtel, R. (2022) · iScience · doi:10.1016/j.isci.2022.103736 · Cited by 10
Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes
Andrades, Á., Álvarez-Pérez, J. C., Patiño-Mercau, J. R., Cuadros, M., Baliñas-Gavira, C., & Medina, P. P. (2022) · Blood · doi:10.1182/blood.2021011708 · Cited by 9
Jeong, N., Kim, S., Park, J. W., Park, S. G., Nam, K., Lee, J. O., Shin, Y., Bae, J. M., Jeong, S., Kim, M. J., et al. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00313-0 · Cited by 10
Zhang, F., Zhang, X., Zhang, H., Lin, D.-D., Fan, H.-L., Guo, S., An, F., Zhao, Y.-Q., Li, J. Y., Schrodi, S. J., et al. (2023) · Epigenetics · doi:10.1080/15592294.2023.2231222 · Cited by 8
Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients
Lang, B., Cao, C., Zhao, X., Wang, Y., Cao, Y., Zhou, X., Zhao, T., Wang, Y., Liu, T., Liang, W., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01207-2 · Cited by 9
Hou, W., Wang, Y., Zhao, Z., Cong, Y., Pang, W., & Tian, Y. (2023) · Complex & Intelligent Systems · doi:10.1007/s40747-023-01068-6 · Cited by 10
A workflow to study mechanistic indicators for driver gene prediction with Moonlight
Nourbakhsh, M., Saksager, A. B., Tom, N., Chen, X., Colaprico, A., Olsen, C., Tiberti, M., & Papaleo, E. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad274 · Cited by 10
Duchenne muscular dystrophy treatment with lentiviral vector containing mini‐dystrophin gene in vivo
Wang, X., Zhu, Y., Liu, T., Zhou, L., Fu, Y., Zhao, J., Li, Y., Zheng, Y., Yang, X., Di, X., et al. (2024) · MedComm · doi:10.1002/mco2.423 · Cited by 9
A large-scale cancer-specific protein–DNA interaction network
Lu, Y., Berenson, A., Lane, R., Guelin, I., Li, Z., Chen, Y., Shah, S., Yin, M., Soto, L. F., Fiszbein, A., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402641 · Cited by 7
ImmuneLENS characterizes systemic immune dysregulation in aging and cancer
Bentham, R. B., Jones, T. P., Black, J. R., Martínez‐Ruiz, C., Dietzen, M., Litovchenko, M., Thol, K., Watkins, T. B. K., Bailey, C., Pich, O., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02086-5 · Cited by 13
Self-citationSystematically Dissecting the Function of RNA-Binding Proteins During Glioma Progression
Wang, J., Qi, J., & Hou, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01394 · Cited by 9
Age‐dependent expression of cancer‐related genes in a long‐lived seabird
Meitern, R., Fort, J., Giraudeau, M., Rattiste, K., Sild, E., & Sepp, T. (2020) · Evolutionary Applications · doi:10.1111/eva.13024 · Cited by 8
Zhao, Y. C., Zhou, Y., Liu, Y., Hao, Y., Li, M., Pu, X., Li, C., & Wen, Z. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03544-z · Cited by 8
Xiao, J. Y., Jin, X., Zhang, C., Zou, H., Chang, Z., Han, N., Li, X., Zhang, Y., & Li, Y. (2021) · Theranostics · doi:10.7150/thno.54150 · Cited by 9
Survival Time Prediction of Breast Cancer Patients Using Feature Selection Algorithm Crystall
Liu, S., Li, H., Zheng, Q., Yang, L., Duan, M., Feng, X., Li, F., Huang, L., & Zhou, F. (2021) · IEEE Access · doi:10.1109/access.2021.3054823 · Cited by 9
Doig, K., Love, C. G., Conway, T., Seleznev, A., Ma, D. K. G., FELLOWES, A. P., Blombery, P. A., & Fox, S. B. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01214-y · Cited by 9
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Huebner, A., Black, J. R., Sarno, F., Pazo-Cid, R., Juez, I., Medina, L., García‐Carbonero, R., Guillén‐Ponce, C., Feliú, J., Alonso, C., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01171-w · Cited by 9
Echeverría‐Garcés, G., Ramos-Medina, M. J., Vargas, R., Cabrera‐Andrade, A., Altamirano-Colina, A., Freire, M. P., Montalvo-Guerrero, J., Rivera-Orellana, S., Echeverría-Espinoza, P., Quiñones, L. A., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1373007 · Cited by 9
Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes
Dong, X., Huang, D., Yi, X., Zhang, S., Wang, Z., Yan, B., Sham, P. C., Chen, K., & Li, M. J. (2020) · Communications Biology · doi:10.1038/s42003-019-0736-4 · Cited by 9
McCoy, M., Shivakumar, V. S., Nimmagadda, S., Jafri, M. S., & Madhavan, S. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2774-9 · Cited by 9
Learning from learning machines: a new generation of AI technology to meet the needs of sciencePreprint
Pion-Tonachini, L., Bouchard, K. E., Martín, H. G., Peisert, S., Holtz, W. B., Aswani, A. J., Dwivedi, D., Wainwright, H. M., Pilania, G., Nachman, B. P., et al. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2111.13786 · Cited by 14
A Suite of Foundation Models Captures the Contextual Interplay Between CodonsPreprint
Naghipourfar, M., Chen, S., Howard, M. K., Macdonald, C. B., Khoroshkin, M., Lee, S., Saberi, A., Hagen, T., Mofrad, M. R. K., Coyote‐Maestas, W., et al. (2024) · SSRN Electronic Journal · doi:10.1101/2024.10.10.617568 · Cited by 10
Othoum, G., & Maher, C. A. (2023) · NAR Cancer · doi:10.1093/narcan/zcad024 · Cited by 8
Comprehensive interrogation of gene lists from genome‐scale cancer screens with oncoEnrichR
Nakken, S., Gundersen, S., Bernal, F. L. M., Polychronopoulos, D., Hovig, E. J., & Wesche, J. (2023) · International Journal of Cancer · doi:10.1002/ijc.34666 · Cited by 8
Niu, R., Guo, Y., & Shang, X. (2024) · iScience · doi:10.1016/j.isci.2024.109387 · Cited by 8
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes
Cao, X., Huber, S., Ahari, A. J., Traube, F. R., Seifert, M., Oakes, C. C., Secheyko, P., Вилов, С. А., Scheller, I. F., Wagner, N., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01331-6 · Cited by 9
Pardi, E., Poma, A. M., Torregrossa, L., Pierotti, L., Borsari, S., Valentina, S. D., Marcocci, C., & Cetani, F. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae441 · Cited by 8
The hallmarks of tissue-agnostic therapies and strategies for early anticancer drug discovery
Mun, J., & Lim, B. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104203 · Cited by 9
The promising role of nanopore sequencing in cancer diagnostics and treatment
Su, X., Lin, Q., Liu, B., Zhou, C., Lu, L., Lin, Z., Si, J., Ding, Y., & Duan, S. (2025) · Cell Insight · doi:10.1016/j.cellin.2025.100229 · Cited by 8
Pan, Y., Berkovska, O., Marathe, S., Mermelekas, G., Gudoitytė, G., Wolide, A. D., Arslan, T., Seashore-Ludlow, B. A., Lehtiö, J., & Orre, L. M. (2025) · iScience · doi:10.1016/j.isci.2025.111864 · Cited by 8
Pal, J., Riester, M., Ganner, A., Ghosh, A., Dhamija, S., Mookherjee, D., Voss, C., Frew, I. J., Kotsis, F., Neumann‐Haefelin, E., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr6375 · Cited by 8
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
Kuras, M., Betancourt, L. H., Hong, R., Szadai, L., Murillo, J. R., Horvatovich, P. L., Plá, I., Eriksson, J. O., Szeitz, B., Deszcz, B., et al. (2025) · Cancers · doi:10.3390/cancers17050832 · Cited by 12
Matthews, S., Fard, V. N., Tollis, M., & Seoighe, C. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf056 · Cited by 8
Detecting and quantifying clonal selection in somatic stem cells
Körber, V., Jakobsen, N. A., Ansari‐Pour, N., Moore, R., Claudino, N., Metzner, M., Thielecke, E., Esau, F., Usukhbayar, B., Salazar, M. A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02217-y · Cited by 14
Zhou, D., Wu, M., Tan, Q., Sun, L., Tu, Y., Zheng, W., Zhu, Y., Yang, M., Hu, K., Hu, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62459-6 · Cited by 8
Su, S.-C., Lin, C., Chen, M.-K., Lee, Y., Su, C., Bai, S., Jangir, H., Chuang, C., Chung, W., Chang, L., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101218 · Cited by 8
Boonyarit, B., Kositchutima, M., Phattalung, T. N., Yamprasert, N., Thuwajit, C., Rungrotmongkol, T., & Nutanong, S. Y. (2025) · GigaScience · doi:10.1093/gigascience/giaf080 · Cited by 7
Stable clonal contribution of lineage-restricted stem cells to human hematopoiesis
Yoshizato, T., Nilsson, C. C., Grasso, F., Högstrand, K., Mazzi, S., Winroth, A., Lehander, M., Barbosa, I., Walldin, G., Blanco, T. M., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02405-w · Cited by 8
Xia, L., Qin, J., & Ye, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04826-0 · Cited by 10
Metadata
- Authors
- Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A.
- Affiliations
- Wellcome Sanger Institute (GB)
- European Bioinformatics Institute (GB)
- ORCID
- Dunham, Ian
- Venue
- Nature Reviews Cancer
- Published
- 2018-10-06
- Volume
- 18
- Issue
- 11
- Pages
- 696-705
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC6450507
- OpenAlex
- W2894573839
- Cited by
- 1,597
- References
- 102
- Citations by year
- 2026: 125 · 2025: 227 · 2024: 242 · 2023: 239 · 2022: 260 · 2021: 250 · 2020: 167 · 2019: 75 · 2018: 8
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- somatic mutations, cancer genetics, gene function, cancer hallmarks, expert curation, cancer genomics
- MeSH terms
- Humans, Mutation, Neoplasms, Censuses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review